Oncology Nursing Update
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:45:46
- More information
Informações:
Synopsis
Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.
